News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
131 Results
Type
Article (6)
Company Profile (1)
Press Release (124)
Section
Business (34)
Deals (2)
FDA (3)
Job Trends (15)
News (48)
Policy (6)
Tag
Alliances (9)
Approvals (5)
Best Places to Work (16)
Biotechnology (1)
Collaboration (3)
Data (1)
Diagnostics (1)
Earnings (15)
Events (28)
Executive appointments (1)
FDA (7)
Funding (2)
Healthcare (9)
IPO (2)
Legal (1)
Medical device (3)
Medtech (3)
Mergers & acquisitions (1)
NextGen: Class of 2026 (1)
Patents (2)
People (16)
Pipeline (4)
Policy (1)
Regulatory (9)
Women's health (9)
Date
Last 7 days (1)
Last 30 days (3)
Last 365 days (20)
2026 (3)
2025 (20)
2024 (28)
2023 (30)
2022 (29)
2021 (11)
2020 (1)
2018 (1)
2015 (1)
2014 (1)
2013 (2)
2012 (1)
2011 (3)
Location
Europe (3)
Georgia (36)
Nevada (1)
United States (36)
131 Results for "femasys".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Femasys Expands European Commercial Footprint with Swiss Partner for FemBloc, FemaSeed, and Portfolio Products
February 4, 2026
·
6 min read
Press Releases
Femasys Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
January 15, 2026
·
5 min read
Press Releases
Femasys Announces Partnership with Refuah Health Center to Expand First-Line Access to FemaSeed® in Community-Based Care
January 14, 2026
·
5 min read
Press Releases
Femasys Announces Third Quarter Financial Results for 2025
November 17, 2025
·
10 min read
Press Releases
Femasys Secures U.S. FDA Clearance for Next-Generation FemVue Diagnostic Device
December 19, 2025
·
5 min read
Press Releases
Femasys Accelerates European Growth for FemBloc® with Kebomed Partnership
September 26, 2025
·
6 min read
Press Releases
PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment
November 26, 2025
·
2 min read
Press Releases
Femasys Secures FDA Approval to Advance Final FemBloc® Trial Phase and $12 Million Financing, with Potential to Reach $58 Million
November 4, 2025
·
9 min read
Press Releases
Femasys Announces Second Quarter Financial Results for 2025
August 8, 2025
·
10 min read
Press Releases
Femasys Secures Regulatory Approval for FemBloc® Permanent Birth Control in New Zealand
September 9, 2025
·
5 min read
1 of 14
Next
